Table 2.
Susceptibility testing for Eikenella corrodens and Gemella bergeri
| Pathogens and antimicrobial agents | MIC (mg/L) and interpretation of susceptibility |
|---|---|
| E. corrodens | |
| Amoxicillin-clavulanic acid | 0.25/0.125 (S) |
| Cefotaxime | 0.06 (S) |
| Imipenem | 0.38 (S) |
| Clindamycin | 24 (NA) |
| G. bergeri | |
| Benzylpenicillin | ≤0.03 (S) |
| Cefotaxime | ≤0.125 (S) |
| Ceftriaxone | ≤0.125 (S) |
| Meropenem | ≤0.125 (S) |
| Vancomycin | 1 (S) |
| Erythromycin | ≤0.125 (S) |
| Levofloxacin | ≤0.25 (S) |
| Clindamycin | ≤0.125 (S) |
MIC Minimum inhibitory concentration, NA Not available in CLSI M45-A3 documents, S Susceptible